Risk of breast cancer in users of combined oestrogen-progestogen HRT compared with users of oestrogen alone

Abstract

Whilst it is clear that women using menopausal hormone replacement therapy (HRT) are at an increased risk of breast cancer, it is uncertain whether combined oestrogen-progestogen preparations increase risk beyond that associated with oestrogen alone. Show more